Xiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8+ T Lymphocytes. (17th July 2013)

• Record Type: Journal Article
• Authors: Li, Wanshuai; Yang, Yang; Ouyang, Zijun; Zhang, Qi; Wang, Lu; Tao, Feifei; Shu, Yongqian; Gu, Yanhong; Xu, Qiang; Sun, Yang
• Other Names: Chen Kevin Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2013(2013)
• Publication Date: 2013-07-17
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2013/879512
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Objectives . To investigate how Xiao-Ai-Ping injection, a traditional Chinese medicine and an ancillary drug in tumor treatment, enhances the antitumor effects of cisplatin on Lewis lung cancer (LLC) cells. Methods . LLC-bearing mice were daily intraperitoneally injected with various doses of cisplatin, Xiao-Ai-Ping, or cisplatin plus Xiao-Ai-Ping, respectively. Body weight and tumor volumes were measured every three days. Results . Combination of Xiao-Ai-Ping and cisplatin yielded significantly better antigrowth and proapoptotic effects on LLC xenografts than sole drug treatment did. In addition, we found that Xiao-Ai-Ping triggered the infiltration of CD8 + T cells, a group of cytotoxic T cells, to LLC xenografts. Furthermore, the mRNA levels of interferon- γ ( ifn- γ ), perforin-1 ( prf-1 ), and granzyme B ( gzmb ) in CD8 + T cells were significantly increased after combination treatment of Xiao-Ai-Ping and cisplatin. In vitro studies showed that Xiao-Ai-Ping markedly upregulated the mRNA levels of ifn- γ, prf-1, and gzmb in CD8 + T cells in a concentration-dependent manner, suggesting that Xiao-Ai-Ping augments the function of CD8 + T cells. Conclusions . Xiao-Ai-Ping promotes the infiltration and function of CD8 + T cells and thus enhances the antigrowth effects of cisplatin on LLC xenografts, which provides new evidence for the combination of Xiao-Ai-Ping and cisplatin in clinic in China.